Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation

Trial Profile

Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 26 Aug 2016

At a glance

  • Drugs Empagliflozin (Primary) ; Linagliptin (Primary) ; Sulodexide (Primary) ; Telmisartan (Primary)
  • Indications Proteinuria; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms ROTATE-2
  • Most Recent Events

    • 11 Jul 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top